...for a company getting federal funding
~Dr Moncef Slaoui, a former pharma executive, was announced last week as a lead figure in President Donald Trump's push for a coronavirus vaccine.
~Slaoui resigned as a director of the company Moderna — which is trialing one vaccine — to take the position.
~However, he continues to hold stock options worth more than $10 million in Moderna, which has seen its stock price skyrocket in recent months.
Moderna's stock climb was helped by an investment from the federal government, of which Slaoui is now a part.
~The holding has been called a potential conflict of interest, as Moderna's vaccine could be a beneficiary of the program Saloui is leading.
https://www.businessinsider.com/moncef-slaoui-leading-trump-vaccine-push-10m-holding-moderna-conflict-2020-5
~Dr Moncef Slaoui, a former pharma executive, was announced last week as a lead figure in President Donald Trump's push for a coronavirus vaccine.
~Slaoui resigned as a director of the company Moderna — which is trialing one vaccine — to take the position.
~However, he continues to hold stock options worth more than $10 million in Moderna, which has seen its stock price skyrocket in recent months.
Moderna's stock climb was helped by an investment from the federal government, of which Slaoui is now a part.
~The holding has been called a potential conflict of interest, as Moderna's vaccine could be a beneficiary of the program Saloui is leading.
https://www.businessinsider.com/moncef-slaoui-leading-trump-vaccine-push-10m-holding-moderna-conflict-2020-5